ERBB2 and breast cancer: Activating mutation of the ERBB2 gene occurred in n = 18/622 BC cases (all except one had a negative HER2/ERBB2 status by IHC/FISH) and was not associated with impaired EPR (p = 0.6345, Figure 3C).